Issue 30

Will India Be the Next Global CDMO Superpower?

Why not sign up for our future email newsletters? Sign up here.

Included in this issue:

LEAD STORY

India: The Next Frontier in Global CDMO Services?

India’s pharmaceutical industry has long been synonymous with cost-effective pharmaceutical manufacturing - particularly when it comes to generic drugs. In recent years, India has been making a significant shift from low-cost generic drug production into CDMO services.  

Read more here.

FEATURED STORIES

Axplora Invests to Advance Life-Changing Therapies in France

Read more here.

Alcami Appoints Tori E. Arens as President of Drug Product

Read more here.

Manufacturing Conglomerate Jabil Establishes CDMO Presence with M&A Play

Read more here.

Novartis to Acquire Anthos Therapeutics in USD 925 Million Deal

Read more here.

Novo Holdings Eyes Expansion of Catalent Amid US Policy Shifts

Read more here.

Frontier Scientific to Construct North America’s Largest Temperature-Controlled Facility Dedicated to Life Sciences

Read more here.

Recipharm Unveils Advanced Aseptic Filling System

Read more here.

Novartis Opens Viral Vector Production Facility in Slovenia

Read more here.

Lifecore Biomedical Expands to Target GLP-1 Injectables and Big Pharma

Read more here.

Rovi Issues Profit Warning Amid Declining CDMO Activity

Read more here.

hVIVO Secures USD 2.5 MN Contract for hMPV Study

Read more here.